Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 0.00 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Mosaic ImmunoEngineering Inc (PK) | CPMV | OTCMarkets | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.60 | 07:13:59 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.60 | 0.60 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0.00 | - | 0.302 - 1.00 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 0.60 | USD |
Mosaic ImmunoEngineering Inc (PK) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.35M | 7.24M | 816.89k | 0 | -1.01M | -0.14 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Mosaic ImmunoEngineering (PK) News
| Date | Time | Source | News Article |
|---|---|---|---|
| 11/02/2023 | 12:17 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 8/03/2023 | 13:44 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CPMV Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.65 | 0.65 | 0.5737 | 0.5905737 | 954 | -0.05 | -7.69% |
| 1 Month | 0.313 | 0.65 | 0.313 | 0.4342319 | 886 | 0.287 | 91.69% |
| 3 Months | 0.556 | 0.65 | 0.302 | 0.4839973 | 1,397 | 0.044 | 7.91% |
| 6 Months | 0.5737 | 0.694 | 0.302 | 0.5207461 | 1,033 | 0.0263 | 4.58% |
| 1 Year | 0.80 | 1.00 | 0.302 | 0.6779032 | 1,025 | -0.20 | -25.00% |
| 3 Years | 3.25 | 3.425 | 0.1001 | 1.18 | 1,098 | -2.65 | -81.54% |
| 5 Years | 3.79 | 5.00 | 0.1001 | 1.65 | 1,118 | -3.19 | -84.17% |
Mosaic ImmunoEngineering (PK) Description
| Mosaic ImmunoEngineering Inc. is a development-stage biotechnology company focused on advancing and eventually commercializing our proprietary immunomodulator platform technology. Our lead immunomodulator product candidate, MIE-101, is based on a naturally occurring plant virus known as Cowpea mosaic virus (or CPMV) which is believed to be non-infectious in animals including mice, dogs and humans. However, because of its virus structure and genetic composition, CPMV elicits a strong immune response when delivered directly into tumors as shown in our preclinical studies. Data from numerous mouse cancer models and in companion dogs with naturally occurring tumors show the ability of intratumoral ("IT") administration of CPMV to result in anti-tumor effects in treated tumors and systemically at other sites of disease through immune activation. |
